Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 259 entries
Sorted by: Best Match Show Resources per page
Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight.

World journal of gastroenterology

Vasques-Monteiro IML, Souza-Mello V.
PMID: 33967554
World J Gastroenterol. 2021 Apr 28;27(16):1738-1750. doi: 10.3748/wjg.v27.i16.1738.

The coronavirus disease 2019 (COVID-19) outbreak has drawn the scientific community's attention to pre-existing metabolic conditions that could aggravate the infection, causing extended viral shedding, prolonged hospitalization, and high death rates. Metabolic dysfunction-associated fatty liver disease (MAFLD) emerges as...

Cite
Vasques-Monteiro IML, Souza-Mello V. Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight. World J Gastroenterol. 2021;27(16):1738-1750doi: 10.3748/wjg.v27.i16.1738.
Vasques-Monteiro, I. M. L., & Souza-Mello, V. (2021). Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight. World journal of gastroenterology, 27(16), 1738-1750. https://doi.org/10.3748/wjg.v27.i16.1738
Vasques-Monteiro, Isabela Macedo Lopes, and Souza-Mello, Vanessa. "Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight." World journal of gastroenterology vol. 27,16 (2021): 1738-1750. doi: https://doi.org/10.3748/wjg.v27.i16.1738
Vasques-Monteiro IML, Souza-Mello V. Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight. World J Gastroenterol. 2021 Apr 28;27(16):1738-1750. doi: 10.3748/wjg.v27.i16.1738. PMID: 33967554; PMCID: PMC8072197.
Copy Download .nbib Format: NLM
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.

Metabolism: clinical and experimental

Polyzos SA, Kountouras J, Mantzoros CS.
PMID: 30502373
Metabolism. 2019 Mar;92:82-97. doi: 10.1016/j.metabol.2018.11.014. Epub 2018 Nov 29.

The obesity epidemic is closely associated with the rising prevalence and severity of nonalcoholic fatty liver disease (NAFLD): obesity has been linked not only with simple steatosis (SS), but also with advanced disease, i.e., nonalcoholic steatohepatitis (NASH), NASH-related cirrhosis...

Cite
Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2018;92:82-97doi: 10.1016/j.metabol.2018.11.014.
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019). Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism: clinical and experimental, 9282-97. https://doi.org/10.1016/j.metabol.2018.11.014
Polyzos, Stergios A, et al. "Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics." Metabolism: clinical and experimental vol. 92 (2019): 82-97. doi: https://doi.org/10.1016/j.metabol.2018.11.014
Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2019 Mar;92:82-97. doi: 10.1016/j.metabol.2018.11.014. Epub 2018 Nov 29. PMID: 30502373.
Copy Download .nbib Format: NLM
Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives.

Liver international : official journal of the International Association for the Study of the Liver

Salomone F, Sharaiha RZ, Boškoski I.
PMID: 32181573
Liver Int. 2020 Jun;40(6):1262-1268. doi: 10.1111/liv.14441. Epub 2020 Apr 06.

Non-alcoholic fatty liver disease (NAFLD) has become the most common liver disease in industrialized countries because of the worldwide epidemic of obesity. Beyond metabolic complications, a subset of patients with NAFLD develop non-alcoholic steatohepatitis (NASH) with fibrosis, which is...

Cite
Salomone F, Sharaiha RZ, Boškoski I. Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives. Liver Int. 2020;40(6):1262-1268doi: 10.1111/liv.14441.
Salomone, F., Sharaiha, R. Z., & Boškoski, I. (2020). Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives. Liver international : official journal of the International Association for the Study of the Liver, 40(6), 1262-1268. https://doi.org/10.1111/liv.14441
Salomone, Federico, et al. "Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives." Liver international : official journal of the International Association for the Study of the Liver vol. 40,6 (2020): 1262-1268. doi: https://doi.org/10.1111/liv.14441
Salomone F, Sharaiha RZ, Boškoski I. Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives. Liver Int. 2020 Jun;40(6):1262-1268. doi: 10.1111/liv.14441. Epub 2020 Apr 06. PMID: 32181573.
Copy Download .nbib Format: NLM
Obesity in Pregnancy: ACOG Practice Bulletin, Number 230.

Obstetrics and gynecology

Sagi-Dain L.
PMID: 34412071
Obstet Gynecol. 2021 Sep 01;138(3):489. doi: 10.1097/AOG.0000000000004527.

No abstract available.

Cite
Sagi-Dain L. Obesity in Pregnancy: ACOG Practice Bulletin, Number 230. Obstet Gynecol. 2021;138(3):489doi: 10.1097/AOG.0000000000004527.
Sagi-Dain, L. (2021). Obesity in Pregnancy: ACOG Practice Bulletin, Number 230. Obstetrics and gynecology, 138(3), 489. https://doi.org/10.1097/AOG.0000000000004527
Sagi-Dain, Lena. "Obesity in Pregnancy: ACOG Practice Bulletin, Number 230." Obstetrics and gynecology vol. 138,3 (2021): 489. doi: https://doi.org/10.1097/AOG.0000000000004527
Sagi-Dain L. Obesity in Pregnancy: ACOG Practice Bulletin, Number 230. Obstet Gynecol. 2021 Sep 01;138(3):489. doi: 10.1097/AOG.0000000000004527. PMID: 34412071.
Copy Download .nbib Format: NLM
Bariatric Surgery in the Treatment of Type 2 Diabetes.

Current diabetes reports

Affinati AH, Esfandiari NH, Oral EA, Kraftson AT.
PMID: 31802258
Curr Diab Rep. 2019 Dec 04;19(12):156. doi: 10.1007/s11892-019-1269-4.

PURPOSE OF REVIEW: We seek to characterize the impact of bariatric surgery on diabetes mellitus by recalling its history, examining the clinical data, exploring the putative mechanisms of action, and anticipating its future.RECENT FINDINGS: Results of clinical trials reveal...

Cite
Affinati AH, Esfandiari NH, Oral EA, et al. Bariatric Surgery in the Treatment of Type 2 Diabetes. Curr Diab Rep. 2019;19(12):156doi: 10.1007/s11892-019-1269-4.
Affinati, A. H., Esfandiari, N. H., Oral, E. A., & Kraftson, A. T. (2019). Bariatric Surgery in the Treatment of Type 2 Diabetes. Current diabetes reports, 19(12), 156. https://doi.org/10.1007/s11892-019-1269-4
Affinati, Alison H, et al. "Bariatric Surgery in the Treatment of Type 2 Diabetes." Current diabetes reports vol. 19,12 (2019): 156. doi: https://doi.org/10.1007/s11892-019-1269-4
Affinati AH, Esfandiari NH, Oral EA, Kraftson AT. Bariatric Surgery in the Treatment of Type 2 Diabetes. Curr Diab Rep. 2019 Dec 04;19(12):156. doi: 10.1007/s11892-019-1269-4. PMID: 31802258; PMCID: PMC7522929.
Copy Download .nbib Format: NLM
Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis.

The British journal of surgery

Almazeedi S, El-Abd R, Al-Khamis A, Albatineh AN, Al-Sabah S.
PMID: 31976551
Br J Surg. 2020 Mar;107(4):348-354. doi: 10.1002/bjs.11494. Epub 2020 Jan 24.

BACKGROUND: Obesity increases the risk of multiple co-morbidities such as type 2 diabetes, cardiovascular disease and most cancers, including colorectal cancer. Currently, the literature presents conflicting results regarding the protective effects of bariatric surgery on the incidence of colorectal...

Cite
Almazeedi S, El-Abd R, Al-Khamis A, et al. Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis. Br J Surg. 2020;107(4):348-354doi: 10.1002/bjs.11494.
Almazeedi, S., El-Abd, R., Al-Khamis, A., Albatineh, A. N., & Al-Sabah, S. (2020). Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis. The British journal of surgery, 107(4), 348-354. https://doi.org/10.1002/bjs.11494
Almazeedi, S, et al. "Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis." The British journal of surgery vol. 107,4 (2020): 348-354. doi: https://doi.org/10.1002/bjs.11494
Almazeedi S, El-Abd R, Al-Khamis A, Albatineh AN, Al-Sabah S. Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis. Br J Surg. 2020 Mar;107(4):348-354. doi: 10.1002/bjs.11494. Epub 2020 Jan 24. PMID: 31976551.
Copy Download .nbib Format: NLM
Obesity and impaired metabolic health in patients with COVID-19.

Nature reviews. Endocrinology

Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS.
PMID: 32327737
Nat Rev Endocrinol. 2020 Jul;16(7):341-342. doi: 10.1038/s41574-020-0364-6.

No abstract available.

Cite
Stefan N, Birkenfeld AL, Schulze MB, et al. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 2020;16(7):341-342doi: 10.1038/s41574-020-0364-6.
Stefan, N., Birkenfeld, A. L., Schulze, M. B., & Ludwig, D. S. (2020). Obesity and impaired metabolic health in patients with COVID-19. Nature reviews. Endocrinology, 16(7), 341-342. https://doi.org/10.1038/s41574-020-0364-6
Stefan, Norbert, et al. "Obesity and impaired metabolic health in patients with COVID-19." Nature reviews. Endocrinology vol. 16,7 (2020): 341-342. doi: https://doi.org/10.1038/s41574-020-0364-6
Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 2020 Jul;16(7):341-342. doi: 10.1038/s41574-020-0364-6. PMID: 32327737; PMCID: PMC7187148.
Copy Download .nbib Format: NLM
Obesity/overweight and risk of allergic rhinitis: A meta-analysis of observational studies.

Allergy

Zhou J, Luo F, Han Y, Lou H, Tang X, Zhang L.
PMID: 31815295
Allergy. 2020 May;75(5):1272-1275. doi: 10.1111/all.14143. Epub 2019 Dec 23.

No abstract available.

Cite
Zhou J, Luo F, Han Y, et al. Obesity/overweight and risk of allergic rhinitis: A meta-analysis of observational studies. Allergy. 2019;75(5):1272-1275doi: 10.1111/all.14143.
Zhou, J., Luo, F., Han, Y., Lou, H., Tang, X., & Zhang, L. (2020). Obesity/overweight and risk of allergic rhinitis: A meta-analysis of observational studies. Allergy, 75(5), 1272-1275. https://doi.org/10.1111/all.14143
Zhou, Jianbo, et al. "Obesity/overweight and risk of allergic rhinitis: A meta-analysis of observational studies." Allergy vol. 75,5 (2020): 1272-1275. doi: https://doi.org/10.1111/all.14143
Zhou J, Luo F, Han Y, Lou H, Tang X, Zhang L. Obesity/overweight and risk of allergic rhinitis: A meta-analysis of observational studies. Allergy. 2020 May;75(5):1272-1275. doi: 10.1111/all.14143. Epub 2019 Dec 23. PMID: 31815295.
Copy Download .nbib Format: NLM
The association of dietary energy density and the risk of obesity, type 2 diabetes and metabolic syndrome: A systematic review and meta-analysis of observational studies.

International journal of clinical practice

Bazshahi E, Sheikhhossein F, Amini MR, Shab-Bidar S.
PMID: 33932083
Int J Clin Pract. 2021 Oct;75(10):e14291. doi: 10.1111/ijcp.14291. Epub 2021 May 17.

OBJECTIVES: There is a growing body of evidence linking dietary energy density (DED) with metabolic disorders like obesity, type 2 diabetes (T2D) and metabolic syndrome (MetS). However, according to our knowledge, there has been no systematic review and mate-analysis...

Cite
Bazshahi E, Sheikhhossein F, Amini MR, et al. The association of dietary energy density and the risk of obesity, type 2 diabetes and metabolic syndrome: A systematic review and meta-analysis of observational studies. Int J Clin Pract. 2021;75(10):e14291doi: 10.1111/ijcp.14291.
Bazshahi, E., Sheikhhossein, F., Amini, M. R., & Shab-Bidar, S. (2021). The association of dietary energy density and the risk of obesity, type 2 diabetes and metabolic syndrome: A systematic review and meta-analysis of observational studies. International journal of clinical practice, 75(10), e14291. https://doi.org/10.1111/ijcp.14291
Bazshahi, Elham, et al. "The association of dietary energy density and the risk of obesity, type 2 diabetes and metabolic syndrome: A systematic review and meta-analysis of observational studies." International journal of clinical practice vol. 75,10 (2021): e14291. doi: https://doi.org/10.1111/ijcp.14291
Bazshahi E, Sheikhhossein F, Amini MR, Shab-Bidar S. The association of dietary energy density and the risk of obesity, type 2 diabetes and metabolic syndrome: A systematic review and meta-analysis of observational studies. Int J Clin Pract. 2021 Oct;75(10):e14291. doi: 10.1111/ijcp.14291. Epub 2021 May 17. PMID: 33932083.
Copy Download .nbib Format: NLM
Comment on "Which Patients with Obesity Are at Risk for Renal Disease?".

Nephron

Li Cavoli G, Tortorici C, Bono L, Ferrantelli A, Azzolina V, Li Cavoli TV, Tralongo A.
PMID: 34547754
Nephron. 2021;145(6):732-733. doi: 10.1159/000519048. Epub 2021 Sep 21.

No abstract available.

Cite
Li Cavoli G, Tortorici C, Bono L, et al. Comment on "Which Patients with Obesity Are at Risk for Renal Disease?". Nephron. 2021;145(6):732-733doi: 10.1159/000519048.
Li Cavoli, G., Tortorici, C., Bono, L., Ferrantelli, A., Azzolina, V., Li Cavoli, T. V., & Tralongo, A. (2021). Comment on "Which Patients with Obesity Are at Risk for Renal Disease?". Nephron, 145(6), 732-733. https://doi.org/10.1159/000519048
Li Cavoli, Gioacchino, et al. "Comment on "Which Patients with Obesity Are at Risk for Renal Disease?"." Nephron vol. 145,6 (2021): 732-733. doi: https://doi.org/10.1159/000519048
Li Cavoli G, Tortorici C, Bono L, Ferrantelli A, Azzolina V, Li Cavoli TV, Tralongo A. Comment on "Which Patients with Obesity Are at Risk for Renal Disease?". Nephron. 2021;145(6):732-733. doi: 10.1159/000519048. Epub 2021 Sep 21. PMID: 34547754.
Copy Download .nbib Format: NLM
Management of Postoperative Complications Following Bariatric and Metabolic Procedures.

The Surgical clinics of North America

Feng XC, Burch M.
PMID: 34537140
Surg Clin North Am. 2021 Oct;101(5):731-753. doi: 10.1016/j.suc.2021.05.017. Epub 2021 Aug 07.

Bariatric and metabolic surgery is a safe and effective treatment of morbid obesity, a disease that continues to increase in prevalence in the United States and worldwide. The two most commonly performed operations are the sleeve gastrectomy and the...

Cite
Feng XC, Burch M. Management of Postoperative Complications Following Bariatric and Metabolic Procedures. Surg Clin North Am. 2021;101(5):731-753doi: 10.1016/j.suc.2021.05.017.
Feng, X. C., & Burch, M. (2021). Management of Postoperative Complications Following Bariatric and Metabolic Procedures. The Surgical clinics of North America, 101(5), 731-753. https://doi.org/10.1016/j.suc.2021.05.017
Feng, Xiaoxi Chelsea, and Burch, Miguel. "Management of Postoperative Complications Following Bariatric and Metabolic Procedures." The Surgical clinics of North America vol. 101,5 (2021): 731-753. doi: https://doi.org/10.1016/j.suc.2021.05.017
Feng XC, Burch M. Management of Postoperative Complications Following Bariatric and Metabolic Procedures. Surg Clin North Am. 2021 Oct;101(5):731-753. doi: 10.1016/j.suc.2021.05.017. Epub 2021 Aug 07. PMID: 34537140.
Copy Download .nbib Format: NLM
Letter: Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults (Diabetes Metab J 2020;44:592-601).

Diabetes & metabolism journal

Kim D.
PMID: 33115214
Diabetes Metab J. 2020 Oct;44(5):777-778. doi: 10.4093/dmj.2020.0202. Epub 2020 Oct 21.

No abstract available.

Cite
Kim D. Letter: Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults (Diabetes Metab J 2020;44:592-601). Diabetes Metab J. 2020;44(5):777-778doi: 10.4093/dmj.2020.0202.
Kim, D. (2020). Letter: Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults (Diabetes Metab J 2020;44:592-601). Diabetes & metabolism journal, 44(5), 777-778. https://doi.org/10.4093/dmj.2020.0202
Kim, Darae. "Letter: Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults (Diabetes Metab J 2020;44:592-601)." Diabetes & metabolism journal vol. 44,5 (2020): 777-778. doi: https://doi.org/10.4093/dmj.2020.0202
Kim D. Letter: Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults (Diabetes Metab J 2020;44:592-601). Diabetes Metab J. 2020 Oct;44(5):777-778. doi: 10.4093/dmj.2020.0202. Epub 2020 Oct 21. PMID: 33115214; PMCID: PMC7643596.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 259 entries